An observational study in ERAS, sponsored by Weibing Tang. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2022-10-25.
Sponsored by Weibing Tang · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Enhanced recovery after surgery (ERAS) is a new mode to optimize perioperative management, the core of which is to reduce perioperative physiological and psychological trauma and stress damage, and accelerate postoperative rehabilitation. ERAS has been gradually introduced in pediatric surgery in recent years, however, there are limited reports on its overall implementation. We aimed to determine the popularity of ERAS among pediatric populations in mainland China.
The application of ERAS in children with congenital biliary dilatation (CBD) was investigated. A total of 31 province-level administrative regions in mainland China were involved and each of them had at least one participating center. A questionnaire was designed to assess the baseline adherence of 17 recovery elements and chief pediatric surgeons at each center were invited to complete.
Weibing Tang is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
chief pediatric surgeons at each center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This investigation was conducted on chief surgeons at each center.
Element adherence
Adherence to an element was determined if the frequency of practice reached specific thresholds as defined.
Time frame: immediately after all the questionnaires are collected
Factors associated with baseline ERAS utilization
Factors associated with baseline ERAS utilization
Time frame: immediately after all the questionnaires are collected
Barriers to implementation
Barriers to implementation
Time frame: immediately after all the questionnaires are collected
Outcomes of concern
Outcomes of concern
Time frame: immediately after all the questionnaires are collected
Ran from Jul 2021 to primary completion in Jul 2022, 12 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Weibing Tang